|

Paclitaxel, Cisplatin Clinical Trials

3 actively recruiting trials

Also known as: Taxol, trial group: CCRT + adjuvant chemotherapy

Pipeline

Phase 3: 2

Top Sponsors

  • RenJi Hospital1
  • Henan Cancer Hospital1
  • Chongqing University Cancer Hospital1

Indications

  • Cancer3
  • Invasive Duct Carcinoma of Breast1
  • Mucinous Breast Cancer1
  • Tubular Breast Cancer1
  • Esophageal Squamous Cell Carcinoma1

Other3 trials

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
Phase 3
Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)
Phase 3
The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.